Dermatologists show promising results using combination therapy for vitiligo patients

The combination of a targeted oral medication with light therapy may enhance repigmentation for patients living with nonsegmental vitiligo, a team of researchers led by Emma Guttman-Yassky, MD, Ph.D., Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, reports.